CIK 0000897448 · Accelerated filer
AMARIN CORP PLCUK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 353 1 6699 020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-08-31 | Kalb Michael Wayne SVP and CFO | Option exercise | +3,054 | 211,118 | ||
| 2021-08-31 | Kalb Michael Wayne SVP and CFO | Shares withheld for taxes | −3,011 | $5.54 | $17K | 208,107 |
| 2021-08-31 | Kalb Michael Wayne SVP and CFO | Option exercise · Restricted Stock Units | −1,527 | 0 | ||
| 2021-08-31 | Kalb Michael Wayne SVP and CFO | Option exercise · Restricted Stock Units | −1,527 | 0 | ||
| 2021-08-31 | Kalb Michael Wayne SVP and CFO | Option exercise · Restricted Stock Units | −3,054 | 0 | ||
| 2021-08-31 | Ketchum Steven B Chief Scientific Officer | Option exercise | +1,527 | 453,687 | ||
| 2021-08-31 | Ketchum Steven B Chief Scientific Officer | Option exercise | +1,527 | 455,214 | ||
| 2021-08-31 | Ketchum Steven B Chief Scientific Officer | Option exercise | +3,054 | 458,268 | ||
| 2021-08-31 | Ketchum Steven B Chief Scientific Officer | Shares withheld for taxes | −3,127 | $5.54 | $17K | 455,141 |
| 2021-08-31 | Ketchum Steven B Chief Scientific Officer | Option exercise · Restricted Stock Units | −1,527 | 0 | ||
| 2021-08-31 | Ketchum Steven B Chief Scientific Officer | Option exercise · Restricted Stock Units | −1,527 | 0 | ||
| 2021-08-31 | Ketchum Steven B Chief Scientific Officer | Option exercise · Restricted Stock Units | −3,054 | 0 | ||
| 2021-08-12 | Kalb Michael Wayne SVP and CFO | Option exercise | +95,000 | $2.19 | $208K | 300,010 |
| 2021-08-12 | Kalb Michael Wayne SVP and CFO | Option exercise | +25,000 | $2.95 | $74K | 325,010 |
| 2021-08-12 | Kalb Michael Wayne SVP and CFO | Sale | −120,000 | $5.25 | $630K | 205,010 |
| 2021-08-12 | Kalb Michael Wayne SVP and CFO | Option exercise · Stock Option (Right to Buy) | −95,000 | 55,000 | ||
| 2021-08-12 | Kalb Michael Wayne SVP and CFO | Option exercise · Stock Option (Right to Buy) | −25,000 | 39,000 | ||
| 2021-08-02 | Berg Aaron EVP, President US | Grant or award · Stock Option (Right to Buy) | +96,750 | 96,750 | ||
| 2021-08-02 | Berg Aaron EVP, President US | Grant or award · Restricted Stock Units | +71,650 | 71,650 | ||
| 2021-08-02 | Kalb Michael Wayne SVP and CFO | Grant or award · Restricted Stock Units | +143,300 | 143,300 |
Page 23 of 67 · 1,339 trades